IMCR - Immunocore Holdings plc

QQQ $ 472.49 $ -2.05 (-0.43 %)

DIA $ 416.26 $ -1.07 (-0.26 %)

SPY $ 562.20 $ -1.67 (-0.3 %)

TLT $ 99.62 $ -1.25 (-1.24 %)

GLD $ 235.53 $ -1.83 (-0.77 %)

Previous Close

$ 34.44

Open

Bid

$ 34.31 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 32.37 - $ 76.98

Volume

394,114

Average Volume

Market Cap

1.72B

Beta (5Y Monthly)

$ 0.64

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

ge-vernova-to-rally-over-30-here-are-10-top-analyst-forecasts-for-tuesday

GE Vernova To Rally Over 30%? Here Are 10 ...
09/17/2024 13:00:39

Analyst Expectations For Immunocore Hldgs'...
09/17/2024 12:00:19

HC Wainwright & Co. Reiterates Buy on Immu...
09/17/2024 10:10:59

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

Needham Maintains Buy on Immunocore Hldgs,...
09/17/2024 09:53:48

Needham analyst Gil Blum maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and lowers the price target from $81 to $78.

Reported Saturday, Immunocore Presented Ph...
09/16/2024 08:53:49

Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancerBrenetafu...

Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 17:04:10

Cantor Fitzgerald analyst Eric Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Overweight.

Immunocore CFO And Head Of Strategy, Brian...
08/29/2024 11:19:01

Di Donato has accepted the role of Chief Executive Officer at a private, early-stage biotech headquartered in San Diego, Califo...

The Latest Analyst Ratings For Immunocore ...
08/28/2024 12:00:35

HC Wainwright & Co. Reiterates Buy on Immu...
08/28/2024 10:14:56

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

Oppenheimer Reiterates Outperform on Immun...
08/09/2024 15:23:42

Oppenheimer analyst Jeff Jones reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Outperform and raises the price target from ...

Deep Dive Into Immunocore Hldgs Stock: Ana...
08/09/2024 12:00:51

Needham Reiterates Buy on Immunocore Hldgs...
08/09/2024 09:50:40

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

Immunocore Hldgs Q2 2024 GAAP EPS $(0.23) ...
08/08/2024 11:25:53

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0....

Peeling Back The Layers: Exploring Immunoc...
07/10/2024 18:00:51

JP Morgan Maintains Overweight on Immunoco...
07/10/2024 16:45:52

JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and lowers the price target from $7...

Immunocore Announces Randomization Of The ...
06/18/2024 11:13:33

HC Wainwright & Co. Reiterates Buy on Immu...
06/05/2024 15:35:41

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Science Applications International Sha...
06/03/2024 17:56:53

Needham Reiterates Buy on Immunocore Hldgs...
06/03/2024 10:22:04

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

Immunocore Reports Updated Phase 1 Breneta...
05/31/2024 20:06:53